Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jacques, Camerlo"'
Autor:
Didier Blaise, Pierre Berger, Djamel Mokart, Jacques Camerlo, Emmanuelle Fougereau, Marc Giovannini, Gilles Houvenaeghel, Olivier Turrini, Christian Chabannon, Gilles Piana, Isabelle Brenot-Rossi, Agnès Tallet, Anthony Gonçalves, Aude Charbonnier, Norbert Vey, Sabrina Grossi, Patrice Viens
Publikováno v:
Clinical Hematology International, Vol 3, Iss 4 (2021)
During the COVID-19 pandemic, it was rapidly established that cancer patients have an increased risk of developing severe forms of the 2019 coronavirus disease (COVID-19) due to a backlog of cancer diagnostics and immunosuppressive treatments. Cancer
Externí odkaz:
https://doaj.org/article/cfb97d61df21416196b03400bab47992
Autor:
Patrice Viens, Daniel Birnbaum, Rémi Houlgatte, Jocelyne Jacquemier, Dominique Maraninchi, Catherine Nguyen, Gilles Houvenaeghel, Carole Tarpin, Rebecca Tagett, Jacques Camerlo, Béatrice Loriod, Valéry Nasser, Emmanuelle Charafe-Jauffret, Jacques Rougemont, Pascal Finetti, François Bertucci
Supplementary Table 3 from Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83d716612feb2766cfcbf6db4bac7c74
https://doi.org/10.1158/0008-5472.22363533.v1
https://doi.org/10.1158/0008-5472.22363533.v1
Autor:
Patrice Viens, Daniel Birnbaum, Rémi Houlgatte, Jocelyne Jacquemier, Dominique Maraninchi, Catherine Nguyen, Gilles Houvenaeghel, Carole Tarpin, Rebecca Tagett, Jacques Camerlo, Béatrice Loriod, Valéry Nasser, Emmanuelle Charafe-Jauffret, Jacques Rougemont, Pascal Finetti, François Bertucci
Supplementary Table 2 from Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7daaf9bfdd1b1c7fd0d60d5df3b9bc2b
https://doi.org/10.1158/0008-5472.22363536.v1
https://doi.org/10.1158/0008-5472.22363536.v1
Autor:
Patrice Viens, Daniel Birnbaum, Rémi Houlgatte, Jocelyne Jacquemier, Dominique Maraninchi, Catherine Nguyen, Gilles Houvenaeghel, Carole Tarpin, Rebecca Tagett, Jacques Camerlo, Béatrice Loriod, Valéry Nasser, Emmanuelle Charafe-Jauffret, Jacques Rougemont, Pascal Finetti, François Bertucci
Inflammatory breast cancer (IBC) is a rare but aggressive form of breast cancer with a 5-year survival limited to ∼40%. Diagnosis, based on clinical and/or pathological criteria, may be difficult. Optimal systemic neoadjuvant therapy and accurate p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::239416e733a97c5f721296acdd4c18b5
https://doi.org/10.1158/0008-5472.c.6493758
https://doi.org/10.1158/0008-5472.c.6493758
Autor:
Patrice Viens, Daniel Birnbaum, Rémi Houlgatte, Jocelyne Jacquemier, Dominique Maraninchi, Catherine Nguyen, Gilles Houvenaeghel, Carole Tarpin, Rebecca Tagett, Jacques Camerlo, Béatrice Loriod, Valéry Nasser, Emmanuelle Charafe-Jauffret, Jacques Rougemont, Pascal Finetti, François Bertucci
Supplementary Table 1 from Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b3baa74cdf46dc739f9f04afedb40a
https://doi.org/10.1158/0008-5472.22363539
https://doi.org/10.1158/0008-5472.22363539
Autor:
Mathilde Guerin, Aurélie Autret, Keyvan Rezai, Alice Hervieu, Jean-Marc Extra, Nicolas Isambert, Magali Provansal, Emmanuelle Charafe-Jauffret, François Bertucci, Patrice Viens, Renaud Sabatier, Anthony Gonçalves, Jacques Camerlo, Mario Campone, François Lokiec, Jihane Pakradouni, Jean-Marie Boher
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
European Journal of Cancer, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
European Journal of Cancer, Elsevier, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
European Journal of Cancer, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
Background Phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin pathway is frequently activated in HER2-positive breast cancer and may play a major role in resistance to trastuzumab. Buparlisib is a pan-class-I PI3K inhibitor with p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da780674565139c3af2f049ea3616dd8
https://doi.org/10.1016/j.ejca.2017.08.025
https://doi.org/10.1016/j.ejca.2017.08.025
Autor:
Jacques Camerlo, Dominique Maraninchi, Dominique Genre, Gérard Serment, Patrice Viens, Naji Salem, Franck Bladou, Gwenaelle Gravis, Geneviève Macquart-Moulin, Valerie-Jeanne Bardou
Publikováno v:
Cancer. 98:1627-1634
BACKGROUND The current Phase II study investigated the clinical benefit, impact on quality of life (QOL), and tolerability of weekly docetaxel in symptomatic patients with metastatic hormone-refractory prostate carcinoma (HRPC). METHODS Patients rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9da5a9e68db42a6fe3b37a7a49f33887
https://doi.org/10.1002/cncr.11687
https://doi.org/10.1002/cncr.11687
Autor:
Marie-Laure Bouscary, Michel Resbeut, Dominique Genre, Geneviève Macquart-Moulin, Jean-Paul Moatti, Patrice Viens, Jacques Camerlo, Dominique Maraninchi, Gwenaelle Gravis
Publikováno v:
Cancer. 85:2190-2199
BACKGROUND This study was designed to investigate the personal experience of patients with nonmetastatic breast carcinoma who were treated with the concurrent administration of radiotherapy and chemotherapy in terms of side effects and quality of lif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::882a4ac56d8f58e13733e742379c82d7
https://doi.org/10.1002/(sici)1097-0142(19990515)85:10<2190::aid-cncr13>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19990515)85:10<2190::aid-cncr13>3.0.co
Publikováno v:
Human Pathology. 25:449-454
Expression of the p53 protein has been detected recently by immunohistochemistry in Hodgkin's disease (HD), but the relationship between p53 expression and the prognosis and clinicopathological heterogeneity of HD is still unclear. To address these q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e0d40aa63c8198ffa0559e851da67e2
https://doi.org/10.1016/0046-8177(94)90116-3
https://doi.org/10.1016/0046-8177(94)90116-3
Autor:
Gwenaelle, Gravis, Franck, Bladou, Naji, Salem, Geneviève, Macquart-Moulin, Gérard, Serment, Jacques, Camerlo, Dominique, Genre, Valérie-Jeanne, Bardou, Dominique, Maraninchi, Patrice, Viens
Publikováno v:
Cancer. 98(8)
The current Phase II study investigated the clinical benefit, impact on quality of life (QOL), and tolerability of weekly docetaxel in symptomatic patients with metastatic hormone-refractory prostate carcinoma (HRPC).Patients received weekly docetaxe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4af7ba37fd509045dbe0b644d8d3600a
https://pubmed.ncbi.nlm.nih.gov/14534878
https://pubmed.ncbi.nlm.nih.gov/14534878